r/HerpesCureResearch

Strategizing pressure for phase 3 trial on pritelivir for the immunocompetent

The FDA finally approved use of pritelivir for immunocompromised carriers. We need to figure out how to pressure Asahi Kasei, AiCuris, and VIDS Research to complete the phase 3 trial including immunocompetent carriers that they canceled. I refuse to sit and wait until the next HPIs hit the market, which won't be until approximately 2029 or likely later, or for them to twiddle their thumbs until they find it's pleasing to them to expand their customer base.

What can we do? Mass email all three of them? Emphasize that they are foregoing profits that could be made from maximizing sales volume? There is momentum with this approval, I want to strategize how best to make use of it.

Thank you everyone, and hope you are doing okay.

reddit.com

u/lilfairyfeetxo — 4 days ago

▲ 27 r/HerpesCureResearch

CRISPR/Cas appears to be more effective at combating active HSV-1 infections than existing medications.

Video: https://youtu.be/lQaWh8VLkiU?is=TSQtipZzFd0B5s3C

What's next? CRISPR/Cas appears to be better able to combat active HSV-1 infections than existing drugs. However, follow-up research is urgently needed to apply this in a targeted manner.

Up until now, the targets of the adjective have been chosen at random. It is now important to determine exactly where the adjective can best be directed so that the cutting is as effective as possible.

It might then be possible to find and eliminate not only the active virus but also the dormant virus. Consequently, the virus will no longer be able to reactivate. It must also be determined how the CRISPR/Cas can be effectively delivered to those infected cells.

Sourceq: https://umcutrechtwkz.foundation/nieuwsbericht/op-weg-naar-een-nieuwe-behandeling-van-herpes-simplex-ooginfecties-door-crispr-cas-technologie/

u/Infinite-Painting420 — 4 days ago

▲ 36 r/HerpesCureResearch

New Adibelivir minor regulatory update

Good morning everyone

On October 9th, a new modification appeared on the CTIS page for the IM-250 trial.

IM-202 1b/2a genital herpes trial received a new non substantial modification (NSM-9) on October 9th, decision was made in the same day and it seems to have been approved. This NSM seems to have concerned the Bulgarian location of the trial.

What it actually contains and modifies is not public, and we can’t actually see it, but we now know there was activity in the trial yesterday.

Thoughts? Thanks for reading. Please consider writing your representative about expediting HSV treatment or reach out to me if interested in advocacy.

reddit.com

u/Classic_Guard_6483 — 5 days ago

▲ 61 r/HerpesCureResearch